Employees facing movement restrictions, plants not operating at full capacity: HUL

“Most of our factories, many of our distribution centres and majority of our suppliers are operating, but not at their full capacity," a spokesperson of HUL told PTI.

PTI

April 21, 2020 / 17:14 IST

live

bselive
nselive

Volume

Todays L/H

FMCG major Hindustan Unilever Limited (HUL) on Tuesday said its factories, though operational, are unable to operate at full capacity as its employees continue to face restriction in movement from local authorities in various states amid coronavirus-induced nationwide lockdown. The company is working with local authorities and state governments to ease out movement restrictions.

“Most of our factories, many of our distribution centres and majority of our suppliers are operating, but not at their full capacity," a spokesperson of HUL told PTI.

Coronavirus News India LIVE Updates

Elaborating further the spokesperson said, “we continue to face local or state restrictions in the movement of our people who are working in essential goods supply chain."

The spokesperson further said, "we continue to work with local and state government authorities to get our operations towards the required capacity that the people in our country expect from us.”

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

Employees facing movement restrictions, plants not operating at full capacity: HUL

“Most of our factories, many of our distribution centres and majority of our suppliers are operating, but not at their full capacity," a spokesperson of HUL told PTI.

Related stories

Subscribe to Tech Newsletters

Employees facing movement restrictions, plants not operating at full capacity: HUL

“Most of our factories, many of our distribution centres and majority of our suppliers are operating, but not at their full capacity," a spokesperson of HUL told PTI.

Related stories

Subscribe to Tech Newsletters

Trending news